1National Committee of Clinical Laboratoy Standards. 2004 24. Performance standards for antimicrobial susceptibility testing; fourteenth Informational supplement . NCCLS document M100-S14. Wayne . Pennsylvania :NCCLS, 2004.1-159.
2National Committee of clinical Laboratoy Standards. 2003. Performance standards for antimicrobial disk susceptibility testing; approved standard-eighth edition. NCCLS document , M2-A8. Wayne . Pennsylvania :NCCLS,2003. 1-70.
3National Committee of clinical Laboratoy Standards. 2003. Methods for dilution,antimicrobial susceptibility testing for bacteria that grow aerobically. M7-A6.6th ed. Wayne . Pennsylvania : NCCLS,2003. 1-50.
4Threlfall EJ ,Ward LR . Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi,United Kingdom.Emerg Infect Dis,2001,7:448-450.
5Poutanen SM.Samonella and reduced ciprofloxacin susceptibility. CMN,2003,25:97.
6Hakanen A,Kotilainen P, Jalava J, et al. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol,1999,37 : 3572-3577.
7Fiebelkorn KR ,Crowford SA,McElmeel ML,et al. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase - negative staphylococci. J Clin Microbiol,2003,41:4740-4744.
